John Peter Stefano Holden
Private Equity Investor chez Foresight Group LLP
Profil
John Peter Stefano Holden is the founder of Tinderbox Working Capital Ltd., which was founded in 2013.
He held the title of Chief Executive Officer at Tinderbox Working Capital Ltd.
Mr. Holden's current job is as a Director at Foresight Group LLP, starting in 2016.
Mr. Holden's former jobs include being a Director-Ventures Development at ANGLE Plc, an Investment Director at Touchstone Innovations Ltd.
from 2007 to 2012, a Non-Executive Director at OSspray Ltd., an Investment Director at Veryan Medical Ltd., a Non-Executive Director at RepRegen Ltd.
from 2012 to 2013, a Director at Cortexica Vision Systems Ltd., a Director at Veryan Holdings Ltd.
from 2008 to 2012, a Director at Technology Group Ltd., a Principal at Hoare Govett Ltd., and a Principal at 3i Venture Capital.
Mr. Holden's education includes an MBA from Cranfield University and an undergraduate degree from the University of Durham.
Postes actifs de John Peter Stefano Holden
Sociétés | Poste | Début |
---|---|---|
Foresight Group LLP
Foresight Group LLP Investment ManagersFinance Foresight Group LLP (Foresight Group) is a private equity subsidiary of Foresight Group CI Ltd founded in 1984 by Bernard William Fairman. The firm is headquartered in London. | Private Equity Investor | 01/11/2016 |
Anciens postes connus de John Peter Stefano Holden
Sociétés | Poste | Fin |
---|---|---|
OSspray Ltd.
OSspray Ltd. Chemicals: Major DiversifiedProcess Industries OSspray Ltd. provides bioactive powders for teeth cutting, cleaning and whitening. It engages in the innovation of biomaterials for minimally invasive dentistry of therapeutic air polishing solutions that restore and maintain tooth structure and overall oral health. The company was founded in 2004 by Paul Robinson, Larry Hench and Ian Dennis Thompson and is headquartered in London, GB. | Director/Board Member | 03/01/2014 |
RepRegen Ltd.
RepRegen Ltd. Medical/Nursing ServicesHealth Services RepRegen Ltd. develops synthetic, biologically-active and tissue engineering products. Its smart biomaterials are designed both to support and to improve cellular growth in vivo. The firm is an emerging medical device company using patent-pending repair and regeneration technology in two platforms designed to mend and regrow tissue in the body. RepRegen's first platform is focused on bone and other (hard) tissue, whereas the second platform is focused on muscle and other (soft) tissue. The company was founded in June 2006 and is headquartered in London, GB. | Director/Board Member | 07/03/2013 |
Veryan Holdings Ltd.
Veryan Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Otsuka Holdings Co., Ltd., Veryan Holdings Ltd. is a holding British company that provides research and development services for clinical trials of novel vascular devices. The private company is based in Oxford, UK and was founded in 2007. | Director/Board Member | 09/11/2012 |
Tinderbox Working Capital Ltd.
Tinderbox Working Capital Ltd. Financial ConglomeratesFinance Tinderbox Working Capital Ltd. develops working capital software solutions. It provides customers with software known as Tinderbox used for invoice financing. The company was founded by John Holden in 2013 and is headquartered in Lechlade, the United Kingdom. | Chief Executive Officer | - |
3i Venture Capital
3i Venture Capital Investment ManagersFinance 3i Venture Capital (3i VC) is the venture capital division of 3i Investments Plc, ultimately owned by 3i Group Plc (LSE: III) in Great Britain. Created in 2001 when 3i aligned their organizational structure along global business lines, 3i VC invests globally in seed- to late-stage technology and healthcare businesses. Based in London, the firm has additional offices in Birmingham, Cambridge, Paris, Boston, San Francisco, Stockholm, Hong Kong, Stuttgart and Munich. | Corporate Officer/Principal | - |
Formation de John Peter Stefano Holden
Cranfield University | Masters Business Admin |
University of Durham | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ANGLE PLC | Distribution Services |
Entreprise privées | 11 |
---|---|
Touchstone Innovations Ltd.
Touchstone Innovations Ltd. Investment ManagersFinance Touchstone Innovations Ltd. engages in the provision of technology and commercialization services. The company was founded by Susan Jane Searle in 1986 and is headquartered in London, the United Kingdom. | Finance |
Foresight Group LLP
Foresight Group LLP Investment ManagersFinance Foresight Group LLP (Foresight Group) is a private equity subsidiary of Foresight Group CI Ltd founded in 1984 by Bernard William Fairman. The firm is headquartered in London. | Finance |
Hoare Govett Ltd. | Finance |
3i Venture Capital
3i Venture Capital Investment ManagersFinance 3i Venture Capital (3i VC) is the venture capital division of 3i Investments Plc, ultimately owned by 3i Group Plc (LSE: III) in Great Britain. Created in 2001 when 3i aligned their organizational structure along global business lines, 3i VC invests globally in seed- to late-stage technology and healthcare businesses. Based in London, the firm has additional offices in Birmingham, Cambridge, Paris, Boston, San Francisco, Stockholm, Hong Kong, Stuttgart and Munich. | Finance |
OSspray Ltd.
OSspray Ltd. Chemicals: Major DiversifiedProcess Industries OSspray Ltd. provides bioactive powders for teeth cutting, cleaning and whitening. It engages in the innovation of biomaterials for minimally invasive dentistry of therapeutic air polishing solutions that restore and maintain tooth structure and overall oral health. The company was founded in 2004 by Paul Robinson, Larry Hench and Ian Dennis Thompson and is headquartered in London, GB. | Process Industries |
RepRegen Ltd.
RepRegen Ltd. Medical/Nursing ServicesHealth Services RepRegen Ltd. develops synthetic, biologically-active and tissue engineering products. Its smart biomaterials are designed both to support and to improve cellular growth in vivo. The firm is an emerging medical device company using patent-pending repair and regeneration technology in two platforms designed to mend and regrow tissue in the body. RepRegen's first platform is focused on bone and other (hard) tissue, whereas the second platform is focused on muscle and other (soft) tissue. The company was founded in June 2006 and is headquartered in London, GB. | Health Services |
Cortexica Vision Systems Ltd.
Cortexica Vision Systems Ltd. Packaged SoftwareTechnology Services Cortexica Vision Systems Ltd. develops image recognition and visual search technology which uses algorithms that mimic the way the human brain recognizes images and objects. The firm’s image search algorithms adapt in real-time to local stimulus patterns and employ a variety of customized wavelet constructions to generate image search and video search results. Its products include findSimilar fashion and findSimilar shoes. The firm operates through its offices located in London and San Francisco. The company was founded by Jeffrey Ng Sing Kwong, Scott White Darren and Anil Anthony Bharath in 2008 and is headquartered in London, the United Kingdom. | Technology Services |
Veryan Holdings Ltd.
Veryan Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Otsuka Holdings Co., Ltd., Veryan Holdings Ltd. is a holding British company that provides research and development services for clinical trials of novel vascular devices. The private company is based in Oxford, UK and was founded in 2007. | Commercial Services |
Technology Group Ltd. | |
Tinderbox Working Capital Ltd.
Tinderbox Working Capital Ltd. Financial ConglomeratesFinance Tinderbox Working Capital Ltd. develops working capital software solutions. It provides customers with software known as Tinderbox used for invoice financing. The company was founded by John Holden in 2013 and is headquartered in Lechlade, the United Kingdom. | Finance |
Veryan Medical Ltd.
Veryan Medical Ltd. BiotechnologyHealth Technology Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom. | Health Technology |